| Literature DB >> 35604902 |
Tooran Nayeri1,2,3, Mahmood Moosazadeh4, Shahabeddin Sarvi1,2, Ahmad Daryani1,2.
Abstract
BACKGROUND: Neospora caninum (N. caninum) is known to be a major cause of reproductive failure in cattle herds around the world. Therefore, the current comprehensive study was performed to estimate the global prevalence of N. caninum infection in bovines that had an abortion and aborted fetuses.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35604902 PMCID: PMC9126370 DOI: 10.1371/journal.pone.0268903
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Flow diagram of the study design process.
Description of the studies included the prevalence of N. caninum in bovines that had an abortion.
| Id | First author (Publication year) | Place of study | Sample | Method | Sample size (n) | Serological results n (%) | Cut off | Molecular results n (%) |
|---|---|---|---|---|---|---|---|---|
| 1 | Reichel and Drake, 1996 [ | New Zealand | Serum | ELISA and IFA | 76 | 27 (35.52) | 1: 200 | -- |
| 2 | Buxton | Scotland | Serum | IFA | 465 | 81 (17.4) | 1: 512 ≤ | -- |
| 3 | Campero | Argentina | Serum | IFA | 9 | 8 (88.88) | 1: 800 | -- |
| 4 | Cox | New Zealand | Serum | IFA | 11 | 9 (81.81) | -- | -- |
| 5 | Venturini | Argentina | Serum | IFA, NAT, and ELISA | 189 | 122 (64.55) | 1: 800 | -- |
| 6 | Pitel | France | Serum | ELISA | 163 | 48 (29.45) | 1: 100 | -- |
| 7 | Morales | Mexico | Serum | ELISA | 32 | 29 (90.62) | -- | -- |
| 8 | De Meerschman | Belgium | Serum | IFA | 163 | 33 (20.24) | ≥ 1: 25 | -- |
| 9 | Václavek | Czech Republic | Serum | ELISA and IFA | 463 | 18 (3.9) | ≥ 1: 640 | -- |
| 10 | Sadrebazzaz | Iran | Serum | IFA | 139 | 27 (19.42) | 1: 200 | -- |
| 11 | López‐Gatius | Spain | Serum | ELISA | 38 | 29 (76.31) | -- | -- |
| 12 | Hall | Australia | Serum | ELISA | 8 | 2 (25) | -- | -- |
| 13 | Santos | Brazil | Serum | IFA | 35 | 5 (14.28) | ≥ 200 | -- |
| 14 | McInnes | Australia | Serum | IFA, ELISA, and nested-PCR | 42 | 37 (88.10) | -- | 13 (30.95) |
| 15 | Sadrebazzaz | Iran | Serum | IFA | 12 | 6 (50) | 1: 200 | -- |
| 16 | Zhang | China | Serum | ELISA | 16 | 12 (75) | -- | -- |
| 17 | Yao | China | Serum | ELISA and nested PCR | 20 | 8 (40) | -- | 0/20 (0) |
| 18 | Basso | Germany | Serum | ELISA | 43 | 38 (88.37) | -- | -- |
| 19 | Nematollahi | Iran | Serum | ELISA and dot-ELISA | 32 | ELISA: 7 (21.87) and dot-ELISA: 5 (15.62) | -- | -- |
| 20 | Shabbir | Pakistan | Serum | ELISA | 141 | 66 (46.8) | -- | -- |
| 21 | Ghalmi | Algeria | Serum | IFA | 5 | 4 (80) | > 1: 200 | -- |
| 22 | Yang | China | Serum | ELISA | 80 | 28 (35) | -- | -- |
| 23 | Nematollahi | Iran | Serum | ELISA | 76 | 14 (18.42) | -- | -- |
| 24 | Razmi | Iran | Serum | ELISA | 200 | 38 (19) | -- | -- |
| 25 | Şuteu | Romania | Serum | ELISA | 9 | 5 (55.55) | 1: 100 | -- |
| 26 | Gavrilović | Serbia | Serum | ELISA | 27 | 7 (25.93) | -- | -- |
| 27 | Gharekhani, 2014 [ | Iran | Serum | ELISA | 85 | 55 (64.70) | -- | -- |
| 28 | Špilovská | Slovak Republic | Serum | ELISA | 4 | 3 (75) | -- | -- |
| 29 | de Macedo | Brazil | Serum | ELISA and PCR | 41 | 21 (51.2) | 1: 100 | 0 (0) |
| 30 | Serrano-Martínez | Peru | Serum | ELISA | 219 | 102 (46.6) | -- | -- |
| 31 | Perotta | Brazil | Serum | No data | 73 | 44 (60.27) | -- | -- |
| 32 | Köse | Turkey | Serum | ELISA | 49 | 8 (16.33) | -- | -- |
ELISA: enzyme-linked immunosorbent assay, IFA: indirect immunofluorescence assay, NAT: N. caninum agglutination test, PCR: polymerase chain reaction, and Nested-PCR: nested-polymerase chain reaction.
Characteristics of the included studies for prevalence of N. caninum in the bovine aborted fetuses.
| Id | First author (Publication year) | Place of study | Sample | Methods | Sample size (n) | Serological results n (%) | Molecular results n (%) | Histopathology and IHC results n (%) |
|---|---|---|---|---|---|---|---|---|
| 1 | Thilsted and Dubey, 1989 [ | USA | Tissue specimens from multiple fetal organs | Histopathology and IHC | 9 | -- | -- | Histopathology: 7/9 (77.77) and IHC: 3/9 (33.33) |
| 2 | Barr | USA | Brain | IHC | 86 | -- | -- | IHC: 72/86 (83.72) |
| 3 | Conrad | USA | Brain | Histopathology and IHC | 2 | -- | -- | Histopathology: 2/2 (100) and IHC: 2/2 (100) |
| 4 | Ogino | Japan | Brain | Histopathology and IHC | 115 | -- | -- | Histopathology: 3/115 (2.60) and IHC: 2/115 (1.74) |
| 5 | Nietfeld | USA | Brain, heart, lung, liver, kidney, placenta, and skeletal muscle | Histopathology and IHC | 664 | -- | -- | Histopathology: 25/664 (3.76) and IHC: 21/664 (3.16) |
| 6 | Jardine and Last, 1995 [ | South Africa | Brain and myocardium | Histopathology and IHC | 144 | -- | -- | Histopathology: 2/144 (1.39) and IHC: 2/144 (1.39) |
| 7 | Obendorf | USA | Brain, heart, kidney, liver, and lung | Histopathology and IHC | 11 | -- | -- | Histopathology: 11/11 (100) and IHC: 3/11 (27.27) |
| 8 | Jamaluddin | USA | Placenta, fetal tissues, and uterine fluid | Histopathology | 595 | -- | -- | Histopathology: 71/595 (11.93) |
| 9 | McAllister | USA | Brain | Histopathology and IHC | 8 | -- | -- | Histopathology: 8/8 (100) and IHC: 7/8 (90) |
| 10 | Buxton | Scotland | Serum | IFA | 547 | 87 (15.9) | -- | -- |
| 11 | Campero | Argentina | Brain, heart, lung, liver, adrenal glands, spleen, kidney, thymus, and skeletal muscle | Histopathology and IHC | 2 | -- | -- | Histopathology: 2/2 (100) and IHC: 2/2 (100) |
| 12 | Perez | Costa Rica | Tissue | IHC | 6 | -- | -- | IHC: 1/6 (16.66) |
| 13 | Gottstein | Switzerland | Brain and fetal heart blood or body cavity fluid samples | Histopathology, IFA, ELISA, and PCR | 83 | 7 (8.43) | 24 (28.91) | Histopathology: 18/24 (75) |
| 14 | Moen | Netherlands | Brain, heart, and liver | Histopathology and IHC | 51 | -- | -- | Histopathology: 50/51 (98.03) and IHC: 40/51 (78.43) |
| 15 | Hattel | USA | Brain, heart, placenta, kidney, liver, and skeletal muscle | Histopathology | 688 | -- | -- | Histopathology: 34/688 (4.94) |
| 16 | Baszler | USA | Brain, heart, kidney, liver, lung, spleen, and placenta | Histopathology, IHC, and PCR | 61 | -- | 30 (49.18) | Histopathology: 34/61 (55.73) and IHC 26/61 (42.62) |
| 17 | Venturini | Argentina | Brain and serum | Histopathology, IFA, agglutination test, and ELISA | 104 | 21 (20.19) | -- | Histopathology: 7/8 (87.5) |
| 18 | González | Spain | Brain and fetal fluids | Histopathology, IHC, and IFA | 81 | 32/63 (50.79) | -- | Histopathology: 36/81 (44.44) and IHC: 25/34 (73.53) |
| 19 | Slotved | Denmark | Fetal fluids | Histopathology, IHC, ELISA, and IFA | 32 | 14 (43.75) | -- | Histopathology: 14/32 (43.75) and IHC: 14/32 (43.75) |
| 20 | Wouda | Netherlands | Brain, heart, and liver | Histopathology | 305 | -- | -- | Histopathology: 221/305 (72.46) |
| 21 | Atkinson | New South Wales | Fetal tissues | Histopathology | 12 | -- | -- | Histopathology: 8/12 (66.66) |
| 22 | Pitel | France | Brain | PCR | 104 | -- | 22 (21.15) | -- |
| 23 | Morales | Mexico | Brain, myocardium, diaphragmatic muscle, liver, lung, kidney, and spleen | Histopathology and IHC | 211 | -- | -- | Histopathology: 73/211 (34.6) and IHC: 41/53 (77.36) |
| 24 | Morales | Mexico | Tissue | Histopathology and IHC | 32 | -- | -- | Histopathology: 22/32 (68.75) and IHC: 17/21 (81) |
| 25 | Collantes-Fernández | Spain | Brain | Histopathology, real-time PCR, and nested-PCR | 12 | -- | 9 (75) | Histopathology: 6/12 (50) |
| 26 | Kim | Korea | Brain, heart, lung, liver, spleen, kidney, spinal cord, skeletal muscle, stomach, and small and large intestines | Histopathology, IHC, IFA, and PCR | 180 | 38 (21.11) | 34/45 (75.55) | Histopathology: 45/180 (25) and IHC: 38/45 (84.44) |
| 27 | Corbellini | Brazil | Brain, heart, lung, liver, kidney, and skeletal muscle | Histopathology and IHC | 46 | -- | -- | Histopathology: 22/46 (47.83) and IHC: 18/22 (81.81) |
| 28 | De Meerschman | Belgium | Brain, heart, liver, and serum | Histopathology, IHC, and IFA | 224 | 10/166 (6.02) | -- | Histopathology: 17/224 (7.59) and IHC: 12/17 (70.59) |
| 29 | Campero | Argentina | Brain, heart, lung, liver, adrenal glands, spleen, kidney, thymus, and skeletal muscle | Histopathology and IHC | 288 | -- | -- | Histopathology: 43/288 (14.93) and IHC: 26/43 (60.46) |
| 30 | Pereira-Bueno | Spain | Brain, heart, and fetal sera or thoracic fluids | Histopathology, IHC, IFA, ELISA, and PCR | 80 | 6/56 (10.7) | 9/59 (15.3) | Histopathology: 25/80 (31.3) and IHC: 7/13 (53.8) |
| 31 | Boger and Hattel, 2003 [ | USA | Adrenal gland, brain, heart, intestine, kidney, liver, lung, lymph node, placenta, spleen, skeletal muscle, and thymus | Histopathology and IHC | 144 | -- | -- | Histopathology: 65/144 (45.14) and IHC: 12/144 (8.33) |
| 32 | Kashiwazaki | Uruguay | Brain | IHC | 2 | -- | -- | IHC: 2/2 (100) |
| 33 | López‐Gatius | Spain | Brain | Histopathology, IHC, and PCR | 2 | -- | 2 (100) | Histopathology: 2/2 (100) and IHC: 2/2 (100) |
| 34 | Habibi | Iran | Brain | Semi-nested PCR | 6 | -- | 4 (66.66) | -- |
| 35 | Khodakaram-Tafti and Ikede, 2005 [ | Canada | Brain and heart | Histopathology and IHC | 10 | -- | -- | Histopathology: 5/10 (50) and IHC: 5/10 (50) |
| 36 | Hall | Australia | Placenta | Histopathology | 7 | -- | -- | Histopathology: 1/7 (14.28) |
| 37 | Santos | Brazil | Fetal tissues | IHC | 5 | -- | -- | IHC: 5/5 (100) |
| 38 | Collantes-Fernández | Spain | Brain, heart, liver, kidney, and lung | Nested-PCR | 220 | -- | 72 (32.7) | Histopathology: 18/24 (75) |
| 39 | Corbellini | Brazil | Brain and/or muscle (cardiac and skeletal), liver, lung, and kidney | Histopathology and IHC | 161 | -- | -- | Histopathology: 37/161 (22.98) and IHC: 34/37 (91.89) |
| 40 | McInnes | Australia | Fetal tissues and serum | Histopathology, IFA, ELISA, and nested-PCR | 42 | -- | 21/42 (50) | Histopathology: 9/19 (47.36) |
| 41 | Medina | Mexico | Brain | Histopathology and nested-PCR | 44 | -- | 35 (79.54) | Histopathology: 20/44 (45.45) |
| 42 | Razmi | Iran | Brain | Histopathology, IHC, and PCR | 100 | -- | 13 (13) | Histopathology: 12/53 (22.64) and IHC: 3/53 (5.66) |
| 43 | Reitt | Switzerland | Brain | Real-time PCR and IHC | 223 | -- | 36/76 (47.36) | IHC: 4/223 (1.79) |
| 44 | Sadrebazzaz | Iran | Fetal sera and fluids and brain | Histopathology, IFA, and semi nested-PCR | 12 | 5 (41.66) | 4 (33) | Histopathology: 3/12 (25) |
| 45 | Zhang | China | Brain, liver, kidney, heart, lung, muscle, and spleen | Histology, IHC, and PCR | 12 | -- | 4 (33.33) | Histopathology: 1/2 (50) and IHC: 1/2 (50) |
| 46 | Pabón | Spain | Brain | Histopathology and PCR | 7 | -- | 6 (85.71) | Histopathology: 6/7 (85.71) |
| 47 | Pescador | Brazil | Brain, heart, lung, liver, kidney, and skeletal muscle | Histopathology and IHC | 258 | -- | -- | Histopathology: 89/258 (34.49) and IHC: 55/258 (21.31) |
| 48 | Escamilla | Mexico | Lung, myocardium, liver, and kidney | Histopathology | 16 | -- | -- | Histopathology: 10/16 (62.5) |
| 49 | Moore | Argentina | Fetal fluids, brain, heart, liver, muscle, and placenta | Histopathology, IHC, IFA, and nested-PCR | 666 | 31/55 (56.4) | 34/70 (48.5) | Histopathology: 70/666 (10.5) and IHC: 49/70 (70) |
| 50 | Yao | China | Brain, heart, lung, liver, spleen, kidney, and skeletal muscle | Nested PCR | 26 | -- | 15 (57.7) | -- |
| 51 | Yildiz | Turkey | Heart, liver, lung, brain, and lymph nodes | Histopathology and IHC | 55 | -- | -- | Histopathology: 6/55 (10.90) and IHC: -- |
| 52 | Salehi | Iran | Brain and placenta | Histopathology and nested-PCR | 19 | -- | 17 (89.47) | Histopathology: 19/19 (100) |
| 53 | Sánchez | Mexico | Brain | Histopathology, IHC, and PCR | 48 | -- | NC5: 12/29 (41.37) and ITS1: 15/29 (51.72) | Histopathology: 29/48 (60.41) and IHC: 21/29 (72.41) |
| 54 | Cabral | Brazil | Brain, heart, kidney, liver, lung, spleen, thymus, and placenta | Histopathology, IHC, and nested-PCR | 105 | -- | 23 (21.90) | Histopathology: 75/105 (71.43) and IHC: 9/105 (8.6) |
| 55 | Razmi | Iran | Brain and fetal fluids | IHC, ELISA, and PCR | 151 | 15 (9.93) | 18 (11.92) | IHC: 6/52 (11.54) |
| 56 | Basso | Germany | Brain | PCR | 20 | -- | 18 (90) | -- |
| 57 | Suteu | Romania | Brain and heart | Histopathology and PCR | 9 | -- | 3 (33.33) | Histopathology: 0/9 (0) |
| 58 | Ghalmi | Algeria | Brain | Histopathology, PCR, and real-time PCR | 5 | -- | 3 (60) | Histopathology: 1/5 (20) |
| 59 | Tramuta | Italy | Abomasal content, brain, lung, spleen, liver, kidney, and muscle | Multiplex PCR | 50 | -- | 7 (14) | -- |
| 60 | dos Santos DS, 2011 [ | Brazil | Central nervous system, heart, skeletal muscle, liver, lung, kidney, spleen, thymus, lymph nodes, ovary, testicle, uterus, and ear skin | Histopathology, IHC, and PCR | 24 | -- | 5 (20.83) | Histopathology: 8/24 (33.33) and IHC: 3/24 (12.5) |
| 61 | Yang | China | Brain | Nested-PCR | 80 | -- | 25 (31.3) | -- |
| 62 | Suteu | Romania | Brain and heart | PCR | 21 | -- | 8 (38.09) | -- |
| 63 | Nematollahi | Iran | Brain, spinal cord, placenta, liver, and heart | Histopathology and PCR | 14 | -- | 6 (42.86) | Histopathology: 14/14 (100) |
| 64 | Razmi | Iran | Brain | PCR | 200 | -- | 23 (11.5) | -- |
| 65 | Suteu | Romania | Brain and heart | Histopathology, IHC, and PCR | 9 | -- | 4 (44.44) | Histopathology: 9/9 (100) and IHC: 2/9 (22.22) |
| 66 | Kamali | Iran | Brain | Histopathology and PCR | 395 | -- | 179 (45.31) | Histopathology: 16/56 (28.57) |
| 67 | Spilovska | Slovak Republic | Brain and serum | ELISA and PCR | 4 | 3 (75) | 3 (75) | -- |
| 68 | Salehi | Iran | Brain | Nested-PCR | 16 | -- | 12 (75) | -- |
| 69 | Medina-Esparza | Mexico | Brain | Nested-PCR | 63 | -- | 27 (42.86) | -- |
| 70 | Ozkaraca | Turkey | Brain, myocardium, liver, lung, kidney, spleen, and thymus | IHC and Duplex PCR | 102 | -- | 26 (25.49) | IHC: 18/102 (17.64) |
| 71 | de Macedo | Brazil | Blood, intrathoracic fluid, brain, heart, liver, and lung | Histopathology, IHC, ELISA, and PCR | 41 | 8/30 (26.7) | 14/36 (38.8) | Histopathology: 29/36 (80.55) and IHC: 9/36 (25) |
| 72 | Kaveh | Iran | Brain, kidney, spleen, liver, and lung | PCR and RT-PCR | 128 | -- | 39 (30.47) | -- |
| 73 | Qian | China | Brain, heart, lung, liver, spleen, kidney, and skeletal muscle | Nested-PCR | 7 | -- | 4 (57.14) | -- |
| 74 | Diaz Cao | Spain | Brain | Real-time PCR | 25 | -- | 2 (8) | -- |
| 75 | Tian | China | Fetal tissues | LF-RPA and nested-PCR | 75 | -- | LF-RPA: 18 (24) and nested PCR: 17 (22.6) | -- |
| 76 | Snak | Brazil | Fetal tissues | PCR | 17 | -- | 9 (52.94) | -- |
| 77 | Moroni | Chile | Brain and optic nerve | Histopathology, IHC, and PCR | 296 | -- | 31 (10.5) | Histopathology: 44/296 (14.9) and IHC: 27/44 (61.36) |
| 78 | Bartley | Scotland | Brain, heart, and placenta | Nested-PCR | 455 | -- | 82 (18.02) | -- |
| 79 | Acici | Turkey | Brain, spleen, liver, lung, amniotic fluid, and fetal membranes | Real-time PCR | 88 | -- | 43 (48.9) | -- |
| 80 | Mahajan | India | Heart, liver, and brain | Histopathology and IHC | 13 | -- | -- | Histopathology: 1/13 (7.69) and IHC: 1/13 (7.69) |
| 81 | Amouei | Iran | Brain | Nested-PCR | 9 | -- | 2 (22.2) | -- |
| 82 | Serrano-Martínez | Peru | Fetal tissues and serum | Histopathology, ELISA, and nested-PCR | 68 | 10 (14.70) | 11 (16.17) | Histopathology: 5/68 (7.35) |
| 83 | Villa | Italy | Brain, lung, and liver | Real-time quantitative PCR | 198 | -- | 55 (27.8) | -- |
| 84 | Salehi | Iran | Brain | Nested-PCR | 78 | -- | 16 (20.5) | -- |
| 85 | Perotta | Brazil | Serum, peritoneal and pleural fluids, brain, heart, lung, liver, spleen, thymus, kidney, and skeletal muscle | Histopathology, IFA, and nested-PCR | 5 | 5 (100) | 1/1 (100) | Histopathology: 1/1 (100) |
| 86 | Dorsch | Argentina | Thoracic-abdominal fluids, brain, cerebellum, spinal cord, heart, lungs, thymus, tongue, skeletal muscle, spleen, abomasum, intestine, liver, kidney, and adrenal glands | Histopathology, IHC, IFA, and nested-PCR | 758 | 59/99 (59.6) | 96/106 (90.6) | Histopathology: 107/758 (14.12) and IHC: 30/62 (48.39) |
| 87 | El-Alfy | Japan | Brain | Nested-PCR | 5 | -- | 5 (100) | -- |
IHC: immunohistochemistry, IFA: indirect immunofluorescence assay, ELISA: enzyme-linked immunosorbent assay, PCR: polymerase chain reaction, Real-time PCR: real-time polymerase chain reaction, Nested-PCR: nested-polymerase chain reaction, RT-PCR: reverse transcription polymerase chain reaction, and LF-RPA assay: lateral flow strips- recombinase polymerase amplification.
Fig 2The reported seroprevalence rate of anti- N. caninum antibodies in bovines that had an abortion by serological methods.
Fig 3The pooled seroprevalence rate of anti- N. caninum antibodies in the bovine aborted fetuses.
Fig 4The prevalence of N. caninum infection in the bovine aborted fetuses using molecular methods.